Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - CBA Florida, Inc. | cbai_ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported): May 15,
2017
CORD BLOOD AMERICA, INC.
(Exact name of registrant as specified in its
charter)
|
Florida
|
|
000-50746
|
|
90-0613888
|
|
(State
or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
|
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
1857 Helm Drive, Las Vegas, NV 89119
(Address of Principal Executive Office) (Zip
Code)
(702) 914-7250
(Registrant’s telephone number, including area
code)
_______________________________
Copies to:
Stephen Morgan
1857 Helm Drive, Las Vegas, NV 89119
Phone: (702) 914-7250
Fax: (702) 914-7251
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
On May 15, 2017, Cord Blood America, Inc. (the
“Company”) issued the Press Release attached as Exhibit
99.1 to this Current Report. The Press Release provides details
related to the Company’s financial results and earnings for
the three month period ended March 31, 2017. The
information included in Exhibit 99.1 is considered to be
“furnished” under the Securities Exchange Act of
1934.
Item 9.01 Financial Statements and
Exhibits.
(d) Exhibits
The following Exhibits are furnished herewith:
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
|
Press Release dated May 15,
2017
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
CORD BLOOD AMERICA, INC.
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
Date:
May 15, 2017
|
By:
|
/s/Stephen
Morgan
|
|
|
|
|
Interim
President, General Counsel and Corporate Secretary
|
|
3